77 related articles for article (PubMed ID: 2784873)
1. [Correlation of the perfusion of liver metastases in angio-CT and PET].
Beyer-Enke SA; Görich J; Strauss LG
Rontgenpraxis; 1989 Mar; 42(3):84-8. PubMed ID: 2784873
[No Abstract] [Full Text] [Related]
2. Colorectal cancer recurrence in the liver: detection by PET.
Yasuda S; Makuuchi Y; Sadahiro S; Mukai M; Tokunaga N; Tajima T; Shohtsu A
Tokai J Exp Clin Med; 1998 Oct; 23(4):167-71. PubMed ID: 10359505
[TBL] [Abstract][Full Text] [Related]
3. [The computed tomography of colorectal tumors with water as the contrast medium].
Gaa J; Deininger HK
Rofo; 1990 Jun; 152(6):723-6. PubMed ID: 2163082
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer: diagnostic potential of CT measurements of hepatic perfusion and implications for contrast enhancement protocols.
Leggett DA; Kelley BB; Bunce IH; Miles KA
Radiology; 1997 Dec; 205(3):716-20. PubMed ID: 9393526
[TBL] [Abstract][Full Text] [Related]
5. [CT arterioportography in the spiral technic for the demonstration of liver metastases].
Helmberger H; Bautz W; Vogel U; Lenz M
Rofo; 1993 May; 158(5):410-5. PubMed ID: 8490148
[TBL] [Abstract][Full Text] [Related]
6. [CT arteriography together with portal venous CT in comparison with anti-CEA-immunoscintigraphy for the detection of liver metastases of colorectal cancer].
Rilinger N; Friedrich JM; Pfeifer T; Tomczak R; Häberle J; Zeitler H; Waidelich HA; Niemann H
Rontgenpraxis; 1992 Dec; 45(12):401-4. PubMed ID: 1492251
[No Abstract] [Full Text] [Related]
7. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
[TBL] [Abstract][Full Text] [Related]
8. Hepatic metastases from colorectal cancer: radiologic strategies for improved selection.
Balfe DM
Radiology; 1992 Oct; 185(1):18-9. PubMed ID: 1523305
[No Abstract] [Full Text] [Related]
9. [Diagnostic value of late CT images of liver metastases in comparison with spiral CT].
Zwicker C; Hering M
Rontgenpraxis; 1997 Apr; 50(4):88-90. PubMed ID: 9182336
[No Abstract] [Full Text] [Related]
10. (15)O-Water PET Study of the Effect of Imatinib, a Selective Platelet-Derived Growth Factor Receptor Inhibitor, Versus Anakinra, an IL-1R Antagonist, on Water-Perfusable Tissue Fraction in Colorectal Cancer Metastases.
Lubberink M; Golla SS; Jonasson M; Rubin K; Glimelius B; Sörensen J; Nygren P
J Nucl Med; 2015 Aug; 56(8):1144-9. PubMed ID: 26069310
[TBL] [Abstract][Full Text] [Related]
11. Perfusion of colorectal liver metastases and uptake of fluorouracil assessed by H2(15)O and [18F]uracil positron emission tomography (PET).
Hohenberger P; Strauss LG; Lehner B; Frohmüller S; Dimitrakopoulou A; Schlag P
Eur J Cancer; 1993; 29A(12):1682-6. PubMed ID: 8398294
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT.
Wildi SM; Gubler C; Hany T; Petrowsky H; Clavien PA; Jochum W; Gerlach T; Fried M; Mullhaupt B
J Clin Ultrasound; 2008 Jan; 36(1):20-6. PubMed ID: 17937421
[TBL] [Abstract][Full Text] [Related]
13. Response assessment of colorectal liver metastases with contrast enhanced CT/18F-FDG PET.
García Vicente AM; Domínguez Ferreras E; Sánchez Pérez V; Poblete García VM; Villa Guzmán JC; Jiménez Aragón F; Pineda Pineda MD; Molino Trinidad C; Soriano Castrejón Á
Eur J Radiol; 2013 Jun; 82(6):e255-61. PubMed ID: 23414715
[TBL] [Abstract][Full Text] [Related]
14. [Functional heterogeneity of liver metastases in 3-phase computerized tomograms].
Kober B; Flentje M; Adolph J; Rieden K; Bieber J; zum Winkel K
Rofo; 1986 Jun; 144(6):707-10. PubMed ID: 3012707
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced ultrasound vs multidetector-computed tomography for detecting liver metastases in colorectal cancer: a prospective, blinded, patient-by-patient analysis.
Rafaelsen SR; Jakobsen A
Colorectal Dis; 2011 Apr; 13(4):420-5. PubMed ID: 20412096
[TBL] [Abstract][Full Text] [Related]
16. [The value of CEA immunoscintigraphy for diagnosis of colorectal cancer and its metastases: results of a prospective study].
Imdahl A; Bräutigam P; Hauenstein KH; Eggstein S; Waninger J; Farthmann EH
Zentralbl Chir; 1994; 119(1):17-22. PubMed ID: 8147155
[TBL] [Abstract][Full Text] [Related]
17. Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.
Abbadi RA; Sadat U; Jah A; Praseedom RK; Jamieson NV; Cheow HK; Whitley S; Ford HE; Wilson CB; Harper SJ; Huguet EL
J Surg Oncol; 2014 Sep; 110(3):313-9. PubMed ID: 24737685
[TBL] [Abstract][Full Text] [Related]
18. [Angio-CT in the diagnosis of liver metastases of colorectal tumors].
Kober B; Schlag P; Herrmann R; Gamroth A; Hermann HJ
Rontgenpraxis; 1984 Sep; 37(9):330-3. PubMed ID: 6505863
[No Abstract] [Full Text] [Related]
19. Arterial perfusion abnormalities of the liver after hepatic arterial infusion chemotherapy and their correlation with changes in the metastases: evaluation with CT and angiography.
Roth J; Wallner B; Safi F
AJR Am J Roentgenol; 1989 Oct; 153(4):751-4. PubMed ID: 2672735
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases.
D'souza MM; Sharma R; Mondal A; Jaimini A; Tripathi M; Saw SK; Singh D; Mishra A; Tripathi RP
Nucl Med Commun; 2009 Feb; 30(2):117-25. PubMed ID: 19057427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]